Success Story: Making Cancer Genomics Data More Accessible and Reusable: NIW Approved for Indian Bioinformatics Software Engineer II Advancing Precision Oncology
Client’s Testimonial:
“This would not have been possible without your guidance and support. Thank you to the entire team, and especially big thanks to my attorney, Zoe, for patiently guiding me through every step of the process and for prioritizing my case with such care and urgency.”
On December 18th, 2025, we received another EB-2 NIW (National Interest Waiver) approval for a Bioinformatics Software Engineer II in the field of Bioinformatics (Approval Notice).
General Field: Bioinformatics
Position at the Time of Case Filing: Bioinformatics Software Engineer II
Country of Origin: India
State of Residence at the Time of Filing: Florida
Approval Notice Date: December 18th, 2025
Processing Time: 1 month, 18 days (Premium Processing Requested)
Case Summary:
We are pleased to share the NIW approval of an Indian bioinformatics software engineer II whose work strengthens the infrastructure behind modern cancer research. At the time of filing, the client was employed in the United States at a leading cancer research and treatment organization, supporting large-scale efforts to curate, standardize, and share high-quality cancer genomics data for broad scientific and clinical use.
Research with National Importance
The petition presented the client’s proposed endeavor as advancing cancer research and improving patient care by making cancer genomics data more accessible and reusable, an area supported as having substantial merit and national importance under the NIW framework. In describing the client’s impact, we emphasized her work on scalable, interoperable data pipelines and contribution systems that help researchers and clinicians use complex genomic and clinical information more efficiently, including support for widely used data-sharing resources in the U.S.
Academic Record and Recognition
The client holds an M.S. in bioinformatics and has documented scholarly output in selective venues, including 7 peer-reviewed journal articles and 6 conference abstracts. The petition also documented 1618 citations, reflecting substantial independent reliance on the client’s work by other researchers in the field.
NIW Approval and Outlook
The I-140 NIW petition was filed on October 30th, 2025, and approved on December 18th, 2025, through premium processing. In the petition, we demonstrated that the client’s work addresses nationally important needs in data-driven cancer research and that the client is well-positioned to continue advancing this endeavor through her ongoing U.S.-based role and sustained record of influential publications and citations.